Correction to: Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer's, but not in frontotemporal dementia

Journal of Neural Transmission
Mirko BiblJens Wiltfang

Abstract

The respective first and last authors of this article, Mirko Bibl and Jens Wiltfang, would like to clarify the issue of the seeming duplicate publication of a figure in two articles.

References

Apr 25, 2012·Journal of Neural Transmission·Mirko BiblJens Wiltfang
Apr 26, 2012·Proteomics. Clinical Applications·Mirko BiblJens Wiltfang

❮ Previous
Next ❯

Citations

Jul 16, 2019·Inorganic Chemistry·Ewelina Stefaniak, Wojciech Bal

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Related Papers

The New England Journal of Medicine
N Petitti
Annals of Neurology
Marcel M VerbeekPhilip Scheltens
© 2022 Meta ULC. All rights reserved